MGMichael R. Garvin

Michael R. Garvin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael R. Garvin has a total of 257 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic loci associated with cocaine use identified using a novel approach to detect epistasis

    by Michael R. Garvin, Andrew W. Bergen, Daniel M. Rosenblum, David Kainer, Sharlee Climer, James J Goedert, Peter J. Attia, Shihui Peng, Qiao Zhang, Stanley H. Weiss

    Background: Cocaine use disorder (CUD) is estimated to be 50% heritable, yet few genetic variants have been robustly associated with risk. During January 2021–June 2024, cocaine was involved in 30% of U.S. overdose deaths. Identifying genetic contributors to CUD could inform diagnostics and treatments. The “missing heritability” may stem from small sample sizes, models that inadequately account for small-effect common variants, and the exclusion of large-effect structural variants like copy number changes. Epistasis likely contributes but remains challenging to detect genome-wide. Results: We focused on epistasis and haplotypes rather than individual SNPs by applying the custom correlation coefficient in BlocBuster to construct allele networks from eQTL SNPs. Testing these regulatory haplotype networks for association with cocaine use in 7,826 individuals with opioid use disorder identified 12 significant associations across two ancestries. For one haplotype, raw genotyping array intensity data revealed a copy number increase at the CYP2D6 locus in individuals of European ancestry. In a subcohort of individuals who co-use cocaine and heroin ( i.e ., speedball), two haplotypes were also significantly associated with HIV infection. One of these involved GPR75, whose ligand, CCL5 (RANTES), is shared with CCR5, a coreceptor for HIV entry. Conclusions: Our findings, integrated with long-read human pan-genomes, support a model in which non-functional copies of CYP2D6 disrupt dopaminergic, glutamatergic, and kynurenine pathways in the brain, contributing to cocaine use severity. The association of additional haplotypes with HIV status in speedball users highlights the genetic contribution to comorbid risk in high-exposure populations.

  • Eating Disorders and Parkinson's Disease—2: Genetic Epidemiology and Shared Genomics

    by Andrew W. Bergen, Carolina Makowski, Michael Garvin, Gulcan Cil, Angeline Krueger, Karlee McGlone, Irene Litvan, Heather Hower, Walter H. Kaye

    Objective: Individuals with anorexia nervosa (AN) share premorbid traits with Parkinson's Disease (PD) (e.g., anxiety) and exhibit a two‐fold relative risk of a reported family history of PD. Published estimates of intra‐ and inter‐disorder genetic architecture were extracted and compared prior to conducting novel analyses to provide evidence for cross‐disorder genetic risk. Methods: National register or meta‐analytic familial, twin, and common variant genome‐wide studies were searched; estimates and findings were extracted and compared. Novel cross‐disorder conditional and conjunctional false discovery rate analyses were performed. Results: Sibling relative risks and additive genetic estimates of the two disorders were similar. AN had greater common variant heritability than PD whether measured via infinitesimal model (linkage disequilibrium score regression, LDSC) or causal mixture model (MiXeR). AN had greater polygenicity than PD (mean (SD) 2.50E‐03 (1.64E‐04) versus 2.72E‐4 (1.47E‐05), p < 0.001), but lower discoverability than PD (4.20E‐05 (2.69E‐06) versus 1.40E‐04 (6.95E‐06), p < 0.001). Global genetic correlation was significant (e.g., bivariate LDSC r g = 0.10, p = 0.0033). Novel analyses identified cross‐disorder enrichment, and cross‐disorder risk at chr3p21.31. Conclusions: Cross‐disorder AN and PD research identified shared risk variants at chr3p21.31, genes and mechanisms (e.g., conditioning, fear, and reward) linked to a shared endophenotype.

  • Eating Disorders and Parkinson's Disease—1: Comorbidities, Neurobiology, and Family History

    by Angeline Krueger, Andrew W. Bergen, Irene Litvan, Vincent Filoteo, Carolina Makowski, Susan Murray, Karlee McGlone, Michael Garvin, Andi Drouin, Alyssa Kauffman, et al.

    Objective: Eating disorders (ED), particularly anorexia nervosa (AN), share neurobiological characteristics with Parkinson's Disease (PD) (e.g., premorbid anxiety, dopaminergic dysfunction, harm avoidance, weight loss), suggesting common vulnerability. The present study built upon these observations, an AN patient's reported family history of Parkinson's Disease (RFHoPD), and AN:PD genetic correlation estimates, by ascertaining RFHoPD in families of individuals with PD. Method: We ascertained RFHoPD among ED patients and community participants, and estimated relative risks (RRs) for AN, Bulimia Nervosa (BN), and Binge Eating Disorder (BED). Results: In the total sample ( N = 1135), we observed increased RFHoPD among patients and community participants meeting criteria for ED diagnoses ( n = 727) versus community participants without an ED diagnosis ( n = 408). For AN, RFHoPD prevalence was 6.6%, versus 3.4% ( χ 2 = 4.638, p = 0.031, RR = 1.935, 95% Confidence Interval [CI] = 1.012–3.768). For BN, RFHoPD prevalence was 7.4%, versus 3.4% ( χ 2 = 4.941, p = 0.026, RR = 2.169, 95% CI = 1.023–4.620). For BED, RFHoPD prevalence was 13.3%, versus 3.4% ( χ 2 = 6.953, p = 0.008, RR = 3.886, 95% CI = 1.108–11.524). Conclusions: ED are associated with elevated RFHoPD. Analyses leveraging disorder‐specific research may improve understanding of shared risk factors.


  • Open Access

    Eating Disorders and Parkinson’s Disease - 1: Comorbidities, Neurobiology and Family History

    by Angeline H Krueger, Andrew W Bergen, Irene Litvan, Vincent Filoteo, Carolina Makowski, Susan Murray, Karlee McGlone, Michael Garvin, Andi Drouin, Alyssa Kauffman, et al.

    Objective: In response to a clinical observation of an Anorexia Nervosa (AN) patient with family history of Parkinson’s Disease (FHoPD), and evidence of similarities in dopamine function, personality, anxiety and weight loss symptoms between AN and PD, we completed a pilot study to estimate FHoPD in families of those with eating disorders (EDs). Method: We ascertained FHoPD among ED patients and community participants, and estimated relative risks (RRs) for AN, Bulimia Nervosa (BN) and Binge Eating Disorder (BED). Results: We observed increased FHoPD among patients and community participants (N=482) meeting criteria for ED diagnoses compared to community participants (N=394) without an ED diagnosis. For AN, FHoPD prevalence was 6.6% vs 3.4%, χ 2 =4.638, p=.031, RR=1.935, 95%CI=1.012-3.768. For BN, FHoPD prevalence was 7.4% vs 3.4%, χ 2 =4.941, p=.026, RR=2.169, 95%CI=1.023-4.620. For BED, FHoPD prevalence was 13.3% vs 3.4%, χ 2 =6.953, p=.008, RR=3.886, 95%CI=1.108-11.524. Conclusions: EDs are associated with an elevated FHoPD. Translational analyses leveraging disorder-specific research resources may benefit our understanding of the genetics and neuroscience of both disorders. Highlights: AN and PD share premorbid anxiety, harm avoidance and dopaminergic dysfunction. FHoPD RRs are two-fold for AN and Bulimia Nervosa (BN) and four-fold for Binge Eating Disorder (BED) in a sample of treatment seeking and community participants. ED and PD familiality, and advances in PD and ED genetics and neuroscience research provide opportunities for cross-disorder research.


  • Open Access

    Eating Disorders and Parkinson’s Disease - 2: Population Burden, Genetic Epidemiology and Shared Genomics

    by Andrew W Bergen, Carolina Makowski, Michael Garvin, Gulcan Cil, Angeline Krueger, Karlee McGlone, Irene Litvan, Walter F Kaye

    Objective: We reviewed the epidemiologic and genomic literature and performed genomic analyses to identify population burdens (Eating Disorders, ED and Parkinson’s Disease, PD) and shared genetic risk (Anorexia Nervosa, AN and PD), after we previously demonstrated two-to four-fold relative risks of a family history of Parkinson’s Disease in families of individuals with ED. Method: We reviewed the epidemiology of both disorders and published genome-wide association studies (GWAS), searched PD GWAS findings with AN associated genome-wide significant SNPs and associated genes and regions, and performed conditional/conjunctional false discovery rate genomic analyses of AN and PD summary statistics to identify shared genetics. Results: The global population burden of ED and PD are similar despite differences in age of onset and sex ratio. GWAS review and linkage disequilibrium analysis showed that genome-wide significant variants from AN GWAS and PD GWAS in the chr3p21.31 region are correlated. We identified a chr3p21.31 variant with joint association with both disorders; this variant has functional linkages to 40 genes. Conclusions: ED and PD share neuropsychological, neurobiological, and genetic risk factors, including association with the complex chr3p21.31 locus. Translational analyses leveraging disorder-specific research resources may benefit our understanding of the genetics and neuropsychiatric mechanisms of both disorders. Highlights: ED and PD have similar age-standardized disability life years (AS-DALYS); the burden of both disorders are expected to increase in the future. Genomic epidemiology literature review reveals AN and PD genetic architectures are highly polygenic (AN >> PD), and, AN variant discoverability is less than PD variant discoverability. AN and PD are jointly associated at rs1352420 at chr3p21.31, a region with multiple AN and PD comorbid and genetically correlated trait associations. Cross-disorder research offers opportunities to identify shared variants and explore mechanistic hypotheses


  • Open Access

    Telomere-to-telomere assemblies of chromosome 10 reveal complex adaptive variation of 3-ketoacyl-CoA-synthases in Populus trichocarpa likely driven by Helitrons

    by David Kainer, Stanton Martin, Daniel Hopp, Sophie Mosher, Timothy J. Tschaplinski, P. Doug Hyatt, Madhavi Z. Martin, Jared M. LeBoldus, Kelsey L. Søndreli, Posy E. Busby, et al.

    The model woody plant Populus trichocarpa displays an atypical alkene-diverse wax cuticle likely driven by copy number variation (CNV) of 3-ketoacyl-CoA synthases (KCS), which has been difficult to confirm with short-read assemblies. Long-read sequencing enables the development of telomere-to-telomere resources to detect cryptic variation, including CNVs, which are currently missed. Integrating this information can improve genomic prediction for breeding and provide insights into the evolutionary basis of important traits. Our analysis of 78 long-read haplotypes from chromosome 10 identified more than twice as many KCS genes as previously reported, and numerous intragenic non-synonymous substitutions. Random Forest predictive models highlighted the importance of Potri.010G079500 in producing very long chain alkenes; however, its absence did not predict previously reported alkene-deficient phenotypes. Instead, alkene levels are best predicted by the combinations of KCS copies. Additionally, amino acid substitutions clustered around ligand and donor binding pockets, suggesting they contribute to differing wax cuticle composition. Finally, each KCS gene and copy was linked to a Helitron transposon. A phylogenetic analysis suggests Helitrons are the evolutionary mechanism for generating KCS tandem arrays. Long-read generated telomere-to-telomere assemblies of P. trichocarpa chromosome 10 revealed large-effect loci critical to genetic studies that are unattainable from short-reads. This new resource produced novel insights into genome structure and function, and a novel mechanism for generating tandem gene duplication. Our results highlight that, given current challenges in annotation and assembly, detailed and focused long-read sequences are key to interpreting complex genomic regions that contain tandem copy number variants.


  • Open Access

    Telomere-to-telomere assemblies reveal complex adaptive variation of 3-ketoacyl-CoA-synthases in Populus trichocarpa likely driven by helitrons

    by David Kainer, Stanton Martin, Daniel Hopp, Sophie Mosher, Timothy J. Tschaplinski, P. Doug Hyatt, Madhavi Z. Martin, Jared M. LeBoldus, Kelsey L. Søndreli, Posy E. Busby, et al.

    Background: The model woody plant Populus trichocarpa displays an atypical alkene-diverse wax cuticle likely driven by copy number variation (CNV) of 3-ketoacyl-CoA synthases ( KCS ), which has been difficult to confirm based on short-read assemblies. New long-read sequencing provides opportunities to develop telomere-to-telomere resources to detect cryptic variation, including CNVs, which are currently missed in traditional analyses. Integrating this information can improve genomic prediction for breeding and provide insights into the evolutionary basis of important traits. Results: Our analysis of 78 telomere-to-telomere long-read haplotypes identified more than twice as many KCS genes as previously reported, along with numerous intragenic non-synonymous substitutions. Random forest predictive models highlighted the importance of Potri . 010G079500 in producing very long chain alkenes; however, its absence did not predict previously reported alkene-deficient phenotypes. Instead, alkene levels are best predicted by the combinations of KCS copies. Amino acid substitutions clustered around ligand and donor binding pockets, suggesting they contribute to differing wax cuticle composition. Finally, each KCS gene and copy was linked to a helitron transposon. A phylogenetic analysis indicates they are the evolutionary mechanism for generating KCS tandem arrays. Conclusions: Long-read sequencing and telomere-to-telomere assembles revealed large-effect loci critical to genetic studies that are unattainable from short-reads. These approaches also have the potential to reveal novel insights into genome structure and function, such as the helitrons identified here. Our results highlight that, given current challenges in annotation and assembly, detailed and focused long-read sequences are key to interpreting complex genomic regions that contain tandem copy number variants.

  • Open Access

    Analyses of GWAS signal using GRIN identify additional genes contributing to suicidal behavior

    by Kyle A. Sullivan, Matthew Lane, Mikaela Cashman, J. Izaak Miller, Mirko Pavicic, Angelica M. Walker, Ashley Cliff, Jonathon Romero, Xuejun Qin, Niamh Mullins, et al.

    Genome-wide association studies (GWAS) identify genetic variants underlying complex traits but are limited by stringent genome-wide significance thresholds. We present GRIN (Gene set Refinement through Interacting Networks), which increases confidence in the expanded gene set by retaining genes strongly connected by biological networks when GWAS thresholds are relaxed. GRIN was validated on both simulated interrelated gene sets as well as multiple GWAS traits. From multiple GWAS summary statistics of suicide attempt, a complex phenotype, GRIN identified additional genes that replicated across independent cohorts and retained biologically interrelated genes despite a relaxed significance threshold. We present a conceptual model of how these retained genes interact through neurobiological pathways that may influence suicidal behavior, and identify existing drugs associated with these pathways that would not have been identified under traditional GWAS thresholds. We demonstrate GRIN’s utility in boosting GWAS results by increasing the number of true positive genes identified from GWAS results.


  • Open Access

    Multi-omic network analysis identifies dysregulated neurobiological pathways in opioid addiction

    by Kyle A. Sullivan, David Kainer, Matthew Lane, Mikaela Cashman, J. Izaak Miller, Michael R. Garvin, Alice Townsend, Bryan C. Quach, Caryn Willis, Peter Kruse, et al.

    Opioid addiction constitutes a public health crisis in the United States and opioids cause the most drug overdose deaths in Americans. Yet, opioid addiction treatments have limited efficacy. To help address this problem, we used network-based machine learning techniques to integrate results from genome-wide association studies (GWAS) of opioid use disorder and problematic prescription opioid misuse with transcriptomic, proteomic, and epigenetic data from the dorsolateral prefrontal cortex (dlPFC) in opioid overdose victims. We identified 211 highly interrelated genes identified by GWAS or dysregulation in the dlPFC of individuals with opioid overdose victims that implicated the Akt, BDNF, and ERK pathways, identifying 414 drugs targeting 48 of these opioid addiction-associated genes. This included drugs used to treat other substance use disorders and antidepressant drugs. Our synthesis of multi-omics using a systems biology approach revealed key gene targets that could contribute to drug repurposing, genetics-informed addiction treatment, and future discovery.


  • Predicting COVID-19 Severity Using a Cut-and-Solve Feature Selection Approach

    by Kenneth Smith, Michael Chan, John Brandenburg, Katarina A Jones, Shawn R. Campagna, Michael Garvin, Alan R. Templeton, Daniel Jacobson, Carlos Cruchaga, Sharlee Climer

    Individuals with coronavirus disease 2019 (COVID-19) infection present in a variety of ways, ranging from asymptomatic or mild cough, to organ failure or death. One of the major challenges for the medical community is the quick and accurate determination of how COVID-19 will progress in an individual. Herein, we introduce a new Cut-and-Solve based feature selection program for identifying predictive feature sets in heterogeneous data. We analyze proteomics data from Washington University to identify models ranging in size from a single feature up to five. Validation of logistic regression models using area under the curve (AUC) were applied for both a holdout data set and an independent data set from Massachusetts General Hospital. A variety of known and novel biomarkers for COVID-19 severity were identified. The best model for predicting severe (ventilation or death) vs. non-severe infection is achieved for CALCOCO2 and STC1, with an average AUC=0.81. Based on the known severity markers, several different proteomic pathways are identified. Enrichment analysis indicates activity associated with inflammatory response, as well as myelination and cardiac function.